Biodexa Pharmaceuticals PLC
NASDAQ:BDRX

Watchlist Manager
Biodexa Pharmaceuticals PLC Logo
Biodexa Pharmaceuticals PLC
NASDAQ:BDRX
Watchlist
Price: 5.9301 USD 3.4% Market Closed
Market Cap: 464.5k USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of BDRX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BDRX Intrinsic Value
Not Available
Base Case Scenario
Compare BDRX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BDRX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Biodexa Pharmaceuticals PLC
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Biodexa Pharmaceuticals PLC

Balance Sheet Decomposition
Biodexa Pharmaceuticals PLC

Current Assets 8.8m
Cash & Short-Term Investments 1.7m
Receivables 715k
Other Current Assets 6.4m
Non-Current Assets 6m
PP&E 324k
Intangibles 5.6m
Efficiency

Free Cash Flow Analysis
Biodexa Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biodexa Pharmaceuticals PLC

Revenue
0 GBP
Operating Expenses
-9.2m GBP
Operating Income
-9.2m GBP
Other Expenses
3.5m GBP
Net Income
-5.7m GBP
Fundamental Scores

BDRX Profitability Score
Profitability Due Diligence

Biodexa Pharmaceuticals PLC's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Negative ROE
23/100
Profitability
Score

Biodexa Pharmaceuticals PLC's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

BDRX Solvency Score
Solvency Due Diligence

Biodexa Pharmaceuticals PLC's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
56/100
Solvency
Score

Biodexa Pharmaceuticals PLC's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BDRX Price Targets Summary
Biodexa Pharmaceuticals PLC

There are no price targets for BDRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Biodexa Pharmaceuticals PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for BDRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y